Skip to content

CareDx CDNA Net Income

Net Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.65B+9.6%
Natera, Inc. logo
Natera, Inc.NTRA
-$85.09M-27.1%
NeoGenomics logo
NeoGenomicsNEO
-$17.11M+34.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$30.03M-90.7%
GeneDx Holdings logo
GeneDx HoldingsWGS
-$63.32M-870%
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
$7.32M-71.5%

Segments

By segment

See full
Reportable Segment$2.81M+127%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
Enterprise value$1.35B-9.7%
P/S3.4×-1.1×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's net income?
CareDx (CDNA) reported net income of $2.81M in Q1 2026.
How has CareDx's net income changed year-over-year?
CareDx's net income increased by 127.1% year-over-year, from -$10.35M to $2.81M.
What is the long-term trend for CareDx's net income?
Over 4 years (2021 to 2025), CareDx's net income has grown at a -8.6% compound annual growth rate (CAGR), from -$30.66M to -$21.35M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.